Gamal-Andre Banat

Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial

Mathias Rummel, N. Niederle, Georg Maschmeyer et al. · The Lancet · 2013 · 1.5K citations

Lymphoid Neoplasia, Rituximab Versus Chop, Oncology +10

Role of Epidermal Growth Factor Inhibition in Experimental Pulmonary Hypertension

Bhola K. Dahal, Teodora Cornitescu, Aleksandra Tretyn et al. · American Journal of Respiratory and Critical Care Medicine · 2009 · 129 citations

Role of the Prostanoid EP4 Receptor in Iloprost-mediated Vasodilatation in Pulmonary Hypertension

Ying‐Ju Lai, Soni Savai Pullamsetti, Eva Dony et al. · American Journal of Respiratory and Critical Care Medicine · 2008 · 86 citations

Pegfilgrastim as hematopoietic support for dose-dense chemoimmunotherapy with R-CHOP-14 as first-line therapy in elderly patients with diffuse large B cell lymphoma

Ulrich Mey, Anna Marie Maier, Ingo G.H. Schmidt‐Wolf et al. · Supportive Care in Cancer · 2007 · 34 citations

Hematological Malignancy, Lymphoid Neoplasia, Dose-dense Chemoimmunotherapy +11

A Combination Hybrid-Based Vaccination/Adoptive Cellular Therapy to Prevent Tumor Growth by Involvement of T Cells

Rajkumar Savai, Ralph T. Schermuly, Soni Savai Pullamsetti et al. · Cancer Research · 2007 · 27 citations

Immunology, Immunoediting, Pathology +20